SE9800905L - Ny terapi vid glomerulonefrit - Google Patents

Ny terapi vid glomerulonefrit

Info

Publication number
SE9800905L
SE9800905L SE9800905A SE9800905A SE9800905L SE 9800905 L SE9800905 L SE 9800905L SE 9800905 A SE9800905 A SE 9800905A SE 9800905 A SE9800905 A SE 9800905A SE 9800905 L SE9800905 L SE 9800905L
Authority
SE
Sweden
Prior art keywords
glomerulonephritis
active substance
glucocorticoid
oral
new therapy
Prior art date
Application number
SE9800905A
Other languages
Unknown language ( )
English (en)
Other versions
SE9800905D0 (sv
SE514128C2 (sv
Inventor
Roger Haellgren
Bengt Fellstroem
Original Assignee
Pharmalink Baslaekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmalink Baslaekemedel Ab filed Critical Pharmalink Baslaekemedel Ab
Priority to SE9800905A priority Critical patent/SE514128C2/sv
Publication of SE9800905D0 publication Critical patent/SE9800905D0/sv
Priority to US09/266,023 priority patent/US6239120B1/en
Priority to AU29686/99A priority patent/AU749199B2/en
Priority to DE69902999T priority patent/DE69902999T2/de
Priority to AT99910932T priority patent/ATE224195T1/de
Priority to KR1020007009283A priority patent/KR20010041204A/ko
Priority to EP99910932A priority patent/EP1056461B1/en
Priority to ES99910932T priority patent/ES2181407T3/es
Priority to PCT/SE1999/000406 priority patent/WO1999047144A1/en
Priority to BR9908838-0A priority patent/BR9908838A/pt
Priority to CA002317796A priority patent/CA2317796A1/en
Priority to CNB998041351A priority patent/CN1152688C/zh
Priority to JP2000536384A priority patent/JP4326696B2/ja
Publication of SE9800905L publication Critical patent/SE9800905L/sv
Publication of SE514128C2 publication Critical patent/SE514128C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE9800905A 1998-03-17 1998-03-17 Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit SE514128C2 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9800905A SE514128C2 (sv) 1998-03-17 1998-03-17 Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
US09/266,023 US6239120B1 (en) 1998-03-17 1999-03-11 Method and means for treating glomerulonephritis
JP2000536384A JP4326696B2 (ja) 1998-03-17 1999-03-16 糸球体腎炎の治療のための方法および手段
EP99910932A EP1056461B1 (en) 1998-03-17 1999-03-16 Glucocorticoids for treating glomerulonephritis
DE69902999T DE69902999T2 (de) 1998-03-17 1999-03-16 Glucocorticoide zur behandlung von glomerulonephitis
AT99910932T ATE224195T1 (de) 1998-03-17 1999-03-16 Glucocorticoide zur behandlung von glomerulonephitis
KR1020007009283A KR20010041204A (ko) 1998-03-17 1999-03-16 사구체신염의 치료 방법 및 수단
AU29686/99A AU749199B2 (en) 1998-03-17 1999-03-16 Method and means for treating glomerulonephritis
ES99910932T ES2181407T3 (es) 1998-03-17 1999-03-16 Glucocorticoides para tratar la glomerulonefritis.
PCT/SE1999/000406 WO1999047144A1 (en) 1998-03-17 1999-03-16 Method and means for treating glomerulonephritis
BR9908838-0A BR9908838A (pt) 1998-03-17 1999-03-16 Uso de um glicocorticóide, processeo para tratar glomerulonefrite aguda ou crÈnica, e, composição farmacêutica para tratar glomerulonefrite
CA002317796A CA2317796A1 (en) 1998-03-17 1999-03-16 Method and means for treating glomerulonephritis
CNB998041351A CN1152688C (zh) 1998-03-17 1999-03-16 糖皮质激素用于制备治疗肾小球肾炎的药剂的用途及该药剂用于治疗IgA 肾病的用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9800905A SE514128C2 (sv) 1998-03-17 1998-03-17 Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit

Publications (3)

Publication Number Publication Date
SE9800905D0 SE9800905D0 (sv) 1998-03-17
SE9800905L true SE9800905L (sv) 1999-09-18
SE514128C2 SE514128C2 (sv) 2001-01-08

Family

ID=20410600

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9800905A SE514128C2 (sv) 1998-03-17 1998-03-17 Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit

Country Status (12)

Country Link
EP (1) EP1056461B1 (sv)
JP (1) JP4326696B2 (sv)
KR (1) KR20010041204A (sv)
CN (1) CN1152688C (sv)
AT (1) ATE224195T1 (sv)
AU (1) AU749199B2 (sv)
BR (1) BR9908838A (sv)
CA (1) CA2317796A1 (sv)
DE (1) DE69902999T2 (sv)
ES (1) ES2181407T3 (sv)
SE (1) SE514128C2 (sv)
WO (1) WO1999047144A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
DE602004028497D1 (de) * 2003-09-15 2010-09-16 Nycomed Gmbh Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen
GB0808537D0 (en) * 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
JP7376582B2 (ja) * 2018-10-22 2023-11-08 イーオーイー オレオ ゲーエムベーハー 成形体への圧縮を目的とした粉末材料用添加剤
US11896719B2 (en) * 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease

Also Published As

Publication number Publication date
DE69902999T2 (de) 2003-06-05
ATE224195T1 (de) 2002-10-15
JP2002506824A (ja) 2002-03-05
BR9908838A (pt) 2000-12-12
ES2181407T3 (es) 2003-02-16
SE9800905D0 (sv) 1998-03-17
AU749199B2 (en) 2002-06-20
CN1293572A (zh) 2001-05-02
JP4326696B2 (ja) 2009-09-09
KR20010041204A (ko) 2001-05-15
SE514128C2 (sv) 2001-01-08
DE69902999D1 (de) 2002-10-24
EP1056461B1 (en) 2002-09-18
EP1056461A1 (en) 2000-12-06
CN1152688C (zh) 2004-06-09
AU2968699A (en) 1999-10-11
CA2317796A1 (en) 1999-09-23
WO1999047144A1 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
PL347671A1 (en) Compounds and compositions for delivering active agents
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
DE60041976D1 (de) Phenoxycarbonsäureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
AU7031500A (en) Therapeutic quinazoline compounds
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
AU3850600A (en) Dalda analogs and their use
WO2003045306A3 (en) Phenoxy amine compounds and compositions for delivering active agents
GEP20043383B (en) Cell Adhesion-Inhibiting Antiinflammatory and Immune-Suppressive Compounds
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
SE9903997D0 (sv) New compounds
BG106057A (en) Method of enhancing the efficacy of anti-tumour agents
SE9802208D0 (sv) Novel compounds
GB9907571D0 (en) Compounds
SE9800905L (sv) Ny terapi vid glomerulonefrit
MXPA01012936A (es) Composicion farmaceutica que contiene sibutramina y orlistat.
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
AU2002236587A1 (en) Compositions for adhesion prevention
SE0002354D0 (sv) New formulation
NZ331374A (en) Phenanthridine compounds and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
NUG Patent has lapsed